Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $465
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice TargetHot
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $440 to $465.
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $440 to $465.